Review



ve cadherin  (Adheren Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Adheren Inc ve cadherin
    HFPF disrupts <t>VE-cadherin-mediated</t> adherens junctions (A) Immunostaining of VE-cadherin (green) and phalloidin (red) after 24 h HFPF treatment. Scale bars, 100 μm. (B) Western blot analysis of VE-cadherin expression. (C) Fractionation analysis shows membranous and cytosolic VE-cadherin levels. Na + /K + -ATPase and GAPDH served as loading controls. Data means SEM. ∗ p < 0.05 and ∗∗ p < 0.01.
    Ve Cadherin, supplied by Adheren Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ve+cadherin/cadherin+ve/pmc13122223-104-8-0
    Average 86 stars, based on 1 article reviews
    ve cadherin - by Bioz Stars, 2026-10
    86/100 stars

    Images

    1) Product Images from "Heart failure pleural fluid impairs endothelial barrier through miR 501-3p mediated ZO 1 remodeling"

    Article Title: Heart failure pleural fluid impairs endothelial barrier through miR 501-3p mediated ZO 1 remodeling

    Journal: iScience

    doi: 10.1016/j.isci.2026.115549

    HFPF disrupts VE-cadherin-mediated adherens junctions (A) Immunostaining of VE-cadherin (green) and phalloidin (red) after 24 h HFPF treatment. Scale bars, 100 μm. (B) Western blot analysis of VE-cadherin expression. (C) Fractionation analysis shows membranous and cytosolic VE-cadherin levels. Na + /K + -ATPase and GAPDH served as loading controls. Data means SEM. ∗ p < 0.05 and ∗∗ p < 0.01.
    Figure Legend Snippet: HFPF disrupts VE-cadherin-mediated adherens junctions (A) Immunostaining of VE-cadherin (green) and phalloidin (red) after 24 h HFPF treatment. Scale bars, 100 μm. (B) Western blot analysis of VE-cadherin expression. (C) Fractionation analysis shows membranous and cytosolic VE-cadherin levels. Na + /K + -ATPase and GAPDH served as loading controls. Data means SEM. ∗ p < 0.05 and ∗∗ p < 0.01.

    Techniques Used: Immunostaining, Western Blot, Expressing, Fractionation



    Similar Products

    cd144 (ve-cadherin) antibody, anti-human, reafinity  (Miltenyi Biotec)
    94
    Miltenyi Biotec cd144 (ve-cadherin) antibody, anti-human, reafinity
    Cd144 (Ve Cadherin) Antibody, Anti Human, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ve+cadherin/CD144+(VE-Cadherin)+Antibody%2C+anti-human%2C+REAfinity/custom%40130-135-356%4041168363
    Average 94 stars, based on 1 article reviews
    cd144 (ve-cadherin) antibody, anti-human, reafinity - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    human ve-cadherin antibody  (Bio-Techne corporation)
    95
    Bio-Techne corporation human ve-cadherin antibody
    Human Ve Cadherin Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ve+cadherin/Human+VE-Cadherin+Antibody/custom%40mab9381%4042103601
    Average 95 stars, based on 1 article reviews
    human ve-cadherin antibody - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier
    anti ve cadherin a0734  (ABclonal Biotechnology)
    94
    ABclonal Biotechnology anti ve cadherin a0734
    Anti Ve Cadherin A0734, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ve+cadherin/VE+Cadherin+Rabbit+pAb/pmc13525964-35-23-29
    Average 94 stars, based on 1 article reviews
    anti ve cadherin a0734 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    ve cadherin  (ABclonal Biotechnology)
    95
    ABclonal Biotechnology ve cadherin
    Ve Cadherin, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ve+cadherin/CD31%2FPECAM1+Rabbit+mAb/bio_rxiv__64898__2026__08__18__745407-71-9-10
    Average 95 stars, based on 1 article reviews
    ve cadherin - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier
    ve cadherin cre  (Jackson Laboratory)
    86
    Jackson Laboratory ve cadherin cre
    Description (A) and characterization of endothelial cell ( ec PD-L1 −/− ) (B, D) or neutrophil ( pmn PD-L1 −/− ) (C, E) restricted constitutive PD-L1 gene-deficient mice. Taconic Knockout Repository [mouse TF0103 (MGI:1926446); Taconic Biosciences Inc., Germantown, NY], CD274/PD-L1 conditional knockout mouse. PD-L1 gene exons 1 to 4 are shown as green boxes and loxP sites flanking exon 2 are depicted as red triangles (A) . Homozygous PD-L1 flox/flox were subsequently crossed <t>to</t> <t>either</t> <t>VE-Cadherin‐Cre</t> (B6.FVB-Tg[Cdh5-cre]7Mlia/J; Strain #:006137; RRID: IMSR_JAX:006137) or the S100a8-Cre (B6.Cg-Tg[S100a8-cre,-EGFP]1IIw/J; Strain #:021614; RRID: IMSR_JAX:021614) mice, obtained from Jackson Labs, to produce either mice homozygous for both the flox PD-L1 and specific cell-lineage Cre promoter genes or mice that were heterozygous for one or both genes that served as “Controls”. Gating strategy and typical flow cytogram/dot plot of select cell-lineage restricted PD-L1 expression [either CD31 and PD-L1 (B) or Ly6G and PD-L1 (C) ] for various breeding outcomes from respective Cre-Lox matings for PD-L1 flox/flox animals with VE-Cadherin‐Cre (B) or PD-L1 flox/flox animals with S100a8-Cre (C) . Summary data for the change in percentage PD-L1 + endothelial cells (CD31 + ) (D) and percentage PD-L1 + neutrophils (Ly6G + ) (E) . A dotted line is provided to indicate median frequency of non-specific antibody binding typically detected using gating strategy during analysis, which was 2.75% ± 1.77% CD31 + PD-L1 + (D) and 2.29 ± 0.50% Ly6G + PD-L1 + (E) , respectively. The presence of a significant difference between groups was established at * p < 0.05 with a Mann–Whittney U test.
    Ve Cadherin Cre, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ve+cadherin/cadherin+cre+ve/pmc13268903-39-1-5
    Average 86 stars, based on 1 article reviews
    ve cadherin cre - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    ve cadherin cdh5 cre mice  (Jackson Laboratory)
    86
    Jackson Laboratory ve cadherin cdh5 cre mice
    Description (A) and characterization of endothelial cell ( ec PD-L1 −/− ) (B, D) or neutrophil ( pmn PD-L1 −/− ) (C, E) restricted constitutive PD-L1 gene-deficient mice. Taconic Knockout Repository [mouse TF0103 (MGI:1926446); Taconic Biosciences Inc., Germantown, NY], CD274/PD-L1 conditional knockout mouse. PD-L1 gene exons 1 to 4 are shown as green boxes and loxP sites flanking exon 2 are depicted as red triangles (A) . Homozygous PD-L1 flox/flox were subsequently crossed <t>to</t> <t>either</t> <t>VE-Cadherin‐Cre</t> (B6.FVB-Tg[Cdh5-cre]7Mlia/J; Strain #:006137; RRID: IMSR_JAX:006137) or the S100a8-Cre (B6.Cg-Tg[S100a8-cre,-EGFP]1IIw/J; Strain #:021614; RRID: IMSR_JAX:021614) mice, obtained from Jackson Labs, to produce either mice homozygous for both the flox PD-L1 and specific cell-lineage Cre promoter genes or mice that were heterozygous for one or both genes that served as “Controls”. Gating strategy and typical flow cytogram/dot plot of select cell-lineage restricted PD-L1 expression [either CD31 and PD-L1 (B) or Ly6G and PD-L1 (C) ] for various breeding outcomes from respective Cre-Lox matings for PD-L1 flox/flox animals with VE-Cadherin‐Cre (B) or PD-L1 flox/flox animals with S100a8-Cre (C) . Summary data for the change in percentage PD-L1 + endothelial cells (CD31 + ) (D) and percentage PD-L1 + neutrophils (Ly6G + ) (E) . A dotted line is provided to indicate median frequency of non-specific antibody binding typically detected using gating strategy during analysis, which was 2.75% ± 1.77% CD31 + PD-L1 + (D) and 2.29 ± 0.50% Ly6G + PD-L1 + (E) , respectively. The presence of a significant difference between groups was established at * p < 0.05 with a Mann–Whittney U test.
    Ve Cadherin Cdh5 Cre Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ve+cadherin/cadherin+cre+ve/pm42161931-790-13-16
    Average 86 stars, based on 1 article reviews
    ve cadherin cdh5 cre mice - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    ve cadherin  (Adheren Inc)
    86
    Adheren Inc ve cadherin
    HFPF disrupts <t>VE-cadherin-mediated</t> adherens junctions (A) Immunostaining of VE-cadherin (green) and phalloidin (red) after 24 h HFPF treatment. Scale bars, 100 μm. (B) Western blot analysis of VE-cadherin expression. (C) Fractionation analysis shows membranous and cytosolic VE-cadherin levels. Na + /K + -ATPase and GAPDH served as loading controls. Data means SEM. ∗ p < 0.05 and ∗∗ p < 0.01.
    Ve Cadherin, supplied by Adheren Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ve+cadherin/cadherin+ve/pmc13122223-104-8-0
    Average 86 stars, based on 1 article reviews
    ve cadherin - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    cells  (Miltenyi Biotec)
    94
    Miltenyi Biotec cells
    HFPF disrupts <t>VE-cadherin-mediated</t> adherens junctions (A) Immunostaining of VE-cadherin (green) and phalloidin (red) after 24 h HFPF treatment. Scale bars, 100 μm. (B) Western blot analysis of VE-cadherin expression. (C) Fractionation analysis shows membranous and cytosolic VE-cadherin levels. Na + /K + -ATPase and GAPDH served as loading controls. Data means SEM. ∗ p < 0.05 and ∗∗ p < 0.01.
    Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ve+cadherin/CD144+(VE-Cadherin)+Antibody%2C+anti-human%2C+REAfinity/bio_rxiv__64898__2026__05__14__725187-84-2-8
    Average 94 stars, based on 1 article reviews
    cells - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Description (A) and characterization of endothelial cell ( ec PD-L1 −/− ) (B, D) or neutrophil ( pmn PD-L1 −/− ) (C, E) restricted constitutive PD-L1 gene-deficient mice. Taconic Knockout Repository [mouse TF0103 (MGI:1926446); Taconic Biosciences Inc., Germantown, NY], CD274/PD-L1 conditional knockout mouse. PD-L1 gene exons 1 to 4 are shown as green boxes and loxP sites flanking exon 2 are depicted as red triangles (A) . Homozygous PD-L1 flox/flox were subsequently crossed to either VE-Cadherin‐Cre (B6.FVB-Tg[Cdh5-cre]7Mlia/J; Strain #:006137; RRID: IMSR_JAX:006137) or the S100a8-Cre (B6.Cg-Tg[S100a8-cre,-EGFP]1IIw/J; Strain #:021614; RRID: IMSR_JAX:021614) mice, obtained from Jackson Labs, to produce either mice homozygous for both the flox PD-L1 and specific cell-lineage Cre promoter genes or mice that were heterozygous for one or both genes that served as “Controls”. Gating strategy and typical flow cytogram/dot plot of select cell-lineage restricted PD-L1 expression [either CD31 and PD-L1 (B) or Ly6G and PD-L1 (C) ] for various breeding outcomes from respective Cre-Lox matings for PD-L1 flox/flox animals with VE-Cadherin‐Cre (B) or PD-L1 flox/flox animals with S100a8-Cre (C) . Summary data for the change in percentage PD-L1 + endothelial cells (CD31 + ) (D) and percentage PD-L1 + neutrophils (Ly6G + ) (E) . A dotted line is provided to indicate median frequency of non-specific antibody binding typically detected using gating strategy during analysis, which was 2.75% ± 1.77% CD31 + PD-L1 + (D) and 2.29 ± 0.50% Ly6G + PD-L1 + (E) , respectively. The presence of a significant difference between groups was established at * p < 0.05 with a Mann–Whittney U test.

    Journal: Frontiers in Immunology

    Article Title: Endothelial cell, but not neutrophil, programmed cell death receptor-ligand 1 loss has a morbid impact on experimental murine shock/sepsis-induced lung injury

    doi: 10.3389/fimmu.2026.1816915

    Figure Lengend Snippet: Description (A) and characterization of endothelial cell ( ec PD-L1 −/− ) (B, D) or neutrophil ( pmn PD-L1 −/− ) (C, E) restricted constitutive PD-L1 gene-deficient mice. Taconic Knockout Repository [mouse TF0103 (MGI:1926446); Taconic Biosciences Inc., Germantown, NY], CD274/PD-L1 conditional knockout mouse. PD-L1 gene exons 1 to 4 are shown as green boxes and loxP sites flanking exon 2 are depicted as red triangles (A) . Homozygous PD-L1 flox/flox were subsequently crossed to either VE-Cadherin‐Cre (B6.FVB-Tg[Cdh5-cre]7Mlia/J; Strain #:006137; RRID: IMSR_JAX:006137) or the S100a8-Cre (B6.Cg-Tg[S100a8-cre,-EGFP]1IIw/J; Strain #:021614; RRID: IMSR_JAX:021614) mice, obtained from Jackson Labs, to produce either mice homozygous for both the flox PD-L1 and specific cell-lineage Cre promoter genes or mice that were heterozygous for one or both genes that served as “Controls”. Gating strategy and typical flow cytogram/dot plot of select cell-lineage restricted PD-L1 expression [either CD31 and PD-L1 (B) or Ly6G and PD-L1 (C) ] for various breeding outcomes from respective Cre-Lox matings for PD-L1 flox/flox animals with VE-Cadherin‐Cre (B) or PD-L1 flox/flox animals with S100a8-Cre (C) . Summary data for the change in percentage PD-L1 + endothelial cells (CD31 + ) (D) and percentage PD-L1 + neutrophils (Ly6G + ) (E) . A dotted line is provided to indicate median frequency of non-specific antibody binding typically detected using gating strategy during analysis, which was 2.75% ± 1.77% CD31 + PD-L1 + (D) and 2.29 ± 0.50% Ly6G + PD-L1 + (E) , respectively. The presence of a significant difference between groups was established at * p < 0.05 with a Mann–Whittney U test.

    Article Snippet: The VE-Cadherin‐Cre (Strain #:006137; RRID: IMSR_JAX:006137) and the S100a8-Cre (Strain #:021614; RRID: IMSR_JAX:021614) breeder mouse strains were also obtained from The Jackson Laboratory (see ).

    Techniques: Knock-Out, Expressing, Binding Assay

    HFPF disrupts VE-cadherin-mediated adherens junctions (A) Immunostaining of VE-cadherin (green) and phalloidin (red) after 24 h HFPF treatment. Scale bars, 100 μm. (B) Western blot analysis of VE-cadherin expression. (C) Fractionation analysis shows membranous and cytosolic VE-cadherin levels. Na + /K + -ATPase and GAPDH served as loading controls. Data means SEM. ∗ p < 0.05 and ∗∗ p < 0.01.

    Journal: iScience

    Article Title: Heart failure pleural fluid impairs endothelial barrier through miR 501-3p mediated ZO 1 remodeling

    doi: 10.1016/j.isci.2026.115549

    Figure Lengend Snippet: HFPF disrupts VE-cadherin-mediated adherens junctions (A) Immunostaining of VE-cadherin (green) and phalloidin (red) after 24 h HFPF treatment. Scale bars, 100 μm. (B) Western blot analysis of VE-cadherin expression. (C) Fractionation analysis shows membranous and cytosolic VE-cadherin levels. Na + /K + -ATPase and GAPDH served as loading controls. Data means SEM. ∗ p < 0.05 and ∗∗ p < 0.01.

    Article Snippet: Adheren junctions modulate cell adhesion via cadherins, and VE-cadherin is one of the major cadherins in endothelial cells.

    Techniques: Immunostaining, Western Blot, Expressing, Fractionation